摘要
目的总结97例心脏瓣膜置换手术围术期麻醉处理经验.方法97例心脏瓣膜病变患者,麻醉诱导采用咪唑安定0.1～0.3mg/kg、芬太尼3～5μg/kg、维库溴铵0.1mg/kg诱导,麻醉维持用芬太尼30～40μg/kg、维库溴铵0.1mg·kg-1·h-1.术中、术后适量给予血管活性药物支持循环功能.结果麻醉诱导期心率与诱导前比较无明显变化(P＞0.05),而血压降低差异有统计学意义(P＜0.05).死亡7例,死亡率7.21%.结论心脏瓣膜置换手术麻醉的关键是保持适当心率,在围术期尤其是在CPB前尽量维持有效的心输出量,术中、术后适量给予血管活性药物支持循环功能.
Objective To summarize the experiences on the anesthesia management of cardiac valve replacement. Methods 97 patients were induced with midazolam 0.1~0.3mg/kg , fentanyl 3～5μg/kg and vecuronium 0.1mg/kg ; were maintained with fentanyl 30～40μg/kg and vecuronium 0.1mg·kg-1·h-1 . Vasoactive drugs were used introperatively and postperatively when necessary to support the circulation. Results There were little changes in HR during and pre-anesthesia (P>0.05), but BP decreased significantly (P<0.05). 1 patient died introperatively and 6 patients died postperatively. Conclusion Keep the effective HR and CO is the key of anesthesia treatment in cardiac valve replacement.Introperatively and postperatively, Vasoactive drugs therapy should be given appropriately.
出处
《中国心血管病研究》
CAS
2005年第2期90-92,共3页
Chinese Journal of Cardiovascular Research
关键词
心脏瓣膜置换
麻醉
cardiac valve replacement
anaesthesia
